NeoGenomics, Inc. (NEO) Ownership

NASDAQ: NEOTop holders, insider trades and short interest.

NEO ownership summary

as of October 18, 2026
Institutions
115.2%
of shares outstanding
Insiders
2.11%
of shares outstanding
Shares outstanding
128.5M
Float
117.0M
shares available to trade
Short interest
13.00%
14.2M shares short
Days to cover
6.99
short interest down 15.3% vs prior month
  • Institutions 115.19%
  • Insiders 2.11%

NEO top institutional holders

20 largest
NeoGenomics, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1BlackRock Inc16.24%20.9M$347.5M+910,860 (+4.6%)June 30, 2026
2First Light Asset Management, LLC9.56%12.3M$204.5M+2.5M (+26.2%)June 30, 2026
3First Trust Advisors L.P.7.87%10.1M$168.4M+4.0M (+64.1%)June 30, 2026
4Greenhouse Funds LLLP6.67%8.6M$142.8M−525,893 (−5.8%)June 30, 2026
5Vanguard Portfolio Management, LLC6.27%8.1M$134.2M+439,175 (+5.8%)June 30, 2026
6Vanguard Capital Management, LLC4.49%5.8M$96.0M+107,194 (+1.9%)June 30, 2026
7State Street Corp4.17%5.4M$89.3M+243,946 (+4.8%)June 30, 2026
8Delaware Management Holdings Inc3.92%5.0M$83.9M+1.6M (+45.9%)June 30, 2026
9BRAIDWELL LP3.83%4.9M$81.9M−699,200 (−12.4%)June 30, 2026
10Schroder Investment Management Group3.38%4.3M$72.3M+774,305 (+21.7%)June 30, 2026
11Geode Capital Management, LLC2.67%3.4M$57.1M+197,051 (+6.1%)June 30, 2026
12Millennium Management LLC2.40%3.1M$51.3M+856,785 (+38.5%)June 30, 2026
13Loomis, Sayles & Company LP1.98%2.5M$42.3M+592,329 (+30.4%)June 30, 2026
14Driehaus Capital Management LLC1.95%2.5M$41.8M+787,095 (+45.7%)June 30, 2026
15Bank of America Corp1.90%2.4M$40.6M−617,869 (−20.2%)June 30, 2026
16Dimensional Fund Advisors, Inc.1.87%2.4M$40.0M−274,924 (−10.3%)June 30, 2026
17Arrowstreet Capital Limited Partnership1.86%2.4M$39.8M+2.4M (0.0%)June 30, 2026
18American Capital Management Inc1.74%2.2M$37.3M−13,171 (−0.6%)June 30, 2026
19D. E. Shaw & Co LP1.71%2.2M$36.5M−2.0M (−47.3%)June 30, 2026
20Samlyn Capital, LLC1.66%2.1M$35.5M−426,012 (−16.7%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 15.4M shares and 7 cut 4.5M.

NEO top mutual fund and ETF holders

20 largest
NeoGenomics, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1iShares Core S&P Small-Cap ETF5.95%7.6M$127.3M+1,818 (+0.0%)September 30, 2026
2First Trust NYSE Arca Biotech ETF4.99%6.4M$106.8M—September 30, 2026
3Vanguard MStar Total Stk Mkt Idx Invest3.23%4.1M$69.0M−6,090 (−0.1%)August 31, 2026
4Nomura Small Cap Core I3.18%4.1M$67.9M—August 31, 2026
5iShares Russell 2000 ETF2.61%3.4M$55.9M−38,720 (−1.1%)September 30, 2026
6Vanguard Small Cap Index2.25%2.9M$48.2M−99,982 (−3.3%)September 30, 2026
7Loomis Sayles Small Cap Growth Instl1.41%1.8M$30.1M+122,428 (+7.3%)August 31, 2026
8Vanguard MStar Small Cap Growth Indx Inv1.25%1.6M$26.8M−104,690 (−6.1%)September 30, 2026
9Fidelity Small Cap Index1.12%1.4M$24.0M+12,757 (+0.9%)July 31, 2026
10Invesco S&P SmallCap Momentum ETF1.02%1.3M$21.9M—September 30, 2026
11State Street SPDR Port S&P 600 Sm CpETF0.92%1.2M$19.6M—September 30, 2026
12iShares Russell 2000 Value ETF0.86%1.1M$18.5M+1,680 (+0.2%)September 30, 2026
13Heptagon Driehaus US Micro Cap Eq C$ Acc0.80%1.0M$17.1M—August 31, 2026
14Glenmede Small Cap Equity Adv0.74%948K$15.8M−434,282 (−31.4%)September 30, 2026
15Vanguard Tax-Managed Small Cap Adm0.71%912K$15.2M—September 30, 2026
16Schroder US Mid Cap Inc0.64%820K$13.7M−125,340 (−13.3%)August 31, 2026
17Schroder US Smaller Companies Acc0.60%777K$12.9M−119,724 (−13.3%)August 31, 2026
18T. Rowe Price Small-Cap Value0.60%775K$12.9M—September 30, 2026
19Vanguard Russell 2000 ETF0.59%754K$12.6M−2,868 (−0.4%)September 30, 2026
20abrdn Healthcare Opportunities0.58%745K$12.4M−22,530 (−2.9%)August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

NEO insider transactions

latest 10
NeoGenomics, Inc. insider transactions
DateNameTransactionPriceSharesValue
2026-01-20Warren StoneSell$12.5022,128$276,600
2025-11-25Alicia C OlivoSell$12.0020,916$250,992
2025-05-27Michael Aaron KellyBuy$7.605,000$38,000
2025-05-12Warren StoneBuy$8.585,700$48,906
2025-05-09Lynn A TetraultBuy$8.147,000$56,980
2025-05-07Stephen M KanovskyBuy$7.784,000$31,120
2025-05-07Gilbert Ray Cisneros, Jr.Buy$8.00——
2025-05-06Anthony P ZookBuy$7.8818,900$148,932
2025-05-05David Brian PerezBuy$7.6310,000$76,300
2025-05-02Jeffrey Scott ShermanBuy$7.5120,000$150,200

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

NEO shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns NEO

Institutional investors own 115.2% of NeoGenomics's shares and insiders 2.11%. The largest holder is BlackRock Inc with 16.24% of the shares (20.9M), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 7 reduced their stake in the latest filings. Short interest is 13.00% of the float, or 6.99 days of average trading volume. The share count rose 105.1% since 2014.

Related: NEO analyst forecast, NEO key metrics. See the NEO stock overview for the latest quote and news.

NEO ownership FAQ

Who owns the most NeoGenomics stock?

The largest shareholders of NeoGenomics are BlackRock Inc (16.24%), First Light Asset Management, LLC (9.56%), First Trust Advisors L.P. (7.87%), Greenhouse Funds LLLP (6.67%), Vanguard Portfolio Management, LLC (6.27%).

What percentage of NeoGenomics is owned by institutions?

Institutions hold 115.2% of NeoGenomics's shares outstanding; insiders hold 2.11%.

Which funds own NeoGenomics?

The largest fund holders of NeoGenomics are iShares Core S&P Small-Cap ETF (5.95%), First Trust NYSE Arca Biotech ETF (4.99%), Vanguard MStar Total Stk Mkt Idx Invest (3.23%), Nomura Small Cap Core I (3.18%), iShares Russell 2000 ETF (2.61%).

What is NeoGenomics's short interest?

14.2M shares of NeoGenomics were sold short, 13.00% of the float; at the average daily volume it would take 6.99 days to cover.

Are insiders buying or selling NeoGenomics?

Of the latest 10 reported insider transactions in NeoGenomics (since May 2, 2025), 8 were purchases and 2 were sales.

How many shares of NeoGenomics are outstanding?

NeoGenomics has 128.5M shares outstanding, of which 117.0M are in the public float.

Diagnostics & Research: ownership